Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Astrazeneca Plc (AZN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 77,404,096
  • Shares Outstanding, K 2,531,200
  • Annual Sales, $ 23,002 M
  • Annual Income, $ 3,499 M
  • 36-Month Beta 0.86
  • Price/Sales 3.36
  • Price/Cash Flow 9.88
  • Price/Book 4.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.63 +3.21%
on 04/21/17
31.88 -4.08%
on 03/27/17
-0.73 (-2.33%)
since 03/24/17
3-Month
26.51 +15.35%
on 01/31/17
31.88 -4.08%
on 03/27/17
+3.86 (+14.45%)
since 01/26/17
52-Week
25.55 +19.69%
on 12/07/16
35.04 -12.73%
on 08/05/16
+0.98 (+3.31%)
since 04/26/16

Most Recent Stories

More News
22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China

22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that James Vail, the Company's ...

AZN : 30.58 (+0.30%)
NVO : 37.36 (+0.76%)
XXII : 1.41 (-2.76%)
PFE : 33.85 (+0.27%)
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies

AbbVie Inc. announced disappointing top-line results from two phase III studies evaluating veliparib in combination with chemotherapy for treatment of patients with squamous non-small cell lung cancer...

AZN : 30.58 (+0.30%)
JNJ : 123.51 (+0.06%)
ABBV : 65.04 (-0.09%)
PFE : 33.85 (+0.27%)
Watch for AstraZeneca to Potentially Rebound After Falling 1.47% Yesterday

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $29.67 to a high of $29.99. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $30.04 on...

AZN : 30.58 (+0.30%)
Watch for AstraZeneca to Potentially Rebound After Falling 1.47% Yesterday

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $29.67 to a high of $29.99. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $30.04 on...

AZN : 30.58 (+0.30%)
IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected

IntelliPharmaCeutics International Inc. (IPCI) reported loss of 7 cents per share in the first quarter of 2017, narrower than both the Zacks Consensus Estimate of a loss of 8 cents and the year-ago loss...

AZN : 30.58 (+0.30%)
ENDP : 11.15 (+1.36%)
NVS : 76.35 (+0.14%)
IPCI : 2.00 (+5.82%)
Pharma Stock Roundup: Merck Gets CRL for Label Expansion Effort, Roche Cancer Drug Tops

Key highlights this week include a complete response letter (CRL) for Merck (MRK) and some positive data from Roche.

MYL : 37.44 (+1.60%)
AZN : 30.58 (+0.30%)
JNJ : 123.51 (+0.06%)
MRK : 62.70 (+0.64%)
RHHBY : 32.2000 (-0.64%)
PFE : 33.85 (+0.27%)
BMY : 53.77 (-0.32%)
5 Reasons Why Sanofi (SNY) is a Good Stock to Buy Now

Paris, France based Sanofi (SNY) is a global healthcare company possessing a diversified product portfolio.

AZN : 30.58 (+0.30%)
ALNY : 54.02 (+5.20%)
REGN : 371.39 (-0.25%)
SNY : 46.42 (+0.04%)
Look for Shares of AstraZeneca to Potentially Rebound after Yesterday's 1.25% Sell Off

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $29.83 to a high of $29.97. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.14 on...

AZN : 30.58 (+0.30%)
After Yesterday's Decline of 1.25%, AstraZeneca Offers Investors Better Value

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $29.83 to a high of $29.97. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.14 on...

AZN : 30.58 (+0.30%)
Infinity Pharmaceuticals Focuses on Lead Candidate IPI-549

We issued an updated report on Infinity Pharmaceuticals, Inc. (INFI) on Apr 7.

AZN : 30.58 (+0.30%)
LLY : 80.96 (-0.30%)
INFI : 2.14 (+3.38%)
BMY : 53.77 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development,...

See More

Support & Resistance

2nd Resistance Point 30.87
1st Resistance Point 30.72
Last Price 30.58
1st Support Level 30.45
2nd Support Level 30.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.